Molecular Advances in Muscular Dystrophy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 1120
Special Issue Editor
2. Université Paris-Saclay, Univ Evry, Inserm, Genethon, Integrare research unit UMR_S951, 91000 Evry, France
Interests: DMD; iPSC; gene therapy; muscle; fibrosis; disease modeling; AAV
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Muscular Dystrophy (MD) is the most common hereditary neuromuscular disease affecting 1:5000 boys, and it is still incurable. The disease is caused by mutations in the dystrophin gene that result in the complete absence of the protein, leading to progressive muscle wasting, wheelchair dependence, and premature death due to cardiac and respiratory complications.
In this Special Issue, I am pleased to invite you, as guest editors, to submit your progress on Duchenne Muscular Dystrophy. All papers covering molecular, genetics, and epigenetic insights into DMD pathogenesis, identifying new therapeutic targets, generating innovative in vitro/in vivo disease models, and using biotherapies are welcome. Feel free to reach out to check the suitability of the topic for the issue. Also, reviews are accepted, especially the ones focused on identifying common challenges and potential solutions.
Dr. Sonia Albini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- (Muscular Dystrophy) MD
- muscle regeneration
- epigenetic regulators
- biotherapeutic approaches
